Title : Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.

Pub. Date : 2010 Sep 1

PMID : 20483353






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In addition, cucurbitacin B/cisplatin treated Hep-2 cells also demonstrated a significant reduction in Bcl-2 and Cyclin B1 protein levels compared to single agent cucurbitacin B or cisplatin treated cells. cucurbitacin B cyclin B1 Mus musculus
2 In addition, cucurbitacin B/cisplatin treated Hep-2 cells also demonstrated a significant reduction in Bcl-2 and Cyclin B1 protein levels compared to single agent cucurbitacin B or cisplatin treated cells. Cisplatin cyclin B1 Mus musculus